|
A hormone
secreted by the intestine after eating high-fat food may be the
newest target for a drug to treat obesity, according to researchers
at Kyoto University in Japan.
Gastric inhibitory
polypeptide (GIP) is secreted from the duodenum in the intestine.
Researchers bred mice that lacked the GIP receptor and thus did
not have the ability to secrete GIP. When the mice were fed a
high-fat diet, they did not gain weight and did not suffer from
insulin resistance, a condition linking obesity with Type 2 diabetes.
Mice lacking
the GIP receptor and the gene for the hormone leptin were even
thinner than mice lacking the GIP receptor alone, according to
the study published in the journal Nature Medicine.
Researchers
speculate that, in the absence of the GIP receptor, fat is not
accumulated in fat cells but is used as the primary energy source.
"Thus,
GIP directly links over-eating to obesity and is a potential target
for anti-obesity drugs," concluded the researchers.
Other
sources:Nature Medicine
|